Co-inheritance of ITGA2B and TUBB1 variants in a family reveals distinct genetic contributions to platelet dysfunction. [PDF]
Bandini P +12 more
europepmc +1 more source
Lattice Resonances in Periodic Arrays of Time‐Modulated Scatterers
This work explores how periodic time modulation alters the collective optical behavior of periodic arrays of scatterers, shedding light on the critical role of collective effects in time‐varying photonic systems and unveiling new opportunities for amplification, active control, and nonreciprocal functionalities.
María Blanco de Paz +3 more
wiley +1 more source
Resistance Exercise Intervention Restores Functional Capacity and Improves Frailty Biomarkers in Centenarians. [PDF]
Marcos-Perez D +11 more
europepmc +1 more source
Frontiers of Bright CEP‐Stable Broadband Infrared Sources
Bright CEP‐stable broadband infrared sources push the limits of ultrafast science by delivering exceptional brightness alongside few‐cycle durations and multi‐octave spectral coverage. This review highlights emerging architectures and nonlinear conversion strategies that scale power while preserving phase stability.
Ugaitz Elu, Jens Biegert
wiley +1 more source
Species Accumulation Stabilizes the Synchronous Responses to the Environment of Vertebrate Communities Worldwide. [PDF]
Picó S, Almaraz P, Godoy O.
europepmc +1 more source
Controlling the Center of Mass Motion of Levitated Particles Using Structured Wavefronts
Optically levitated particles have great potential for quantum‐enhanced sensing. Precise control of the trapping beam is crucial to improve the stability and confinement of these systems. Here, we study how structured wavefronts can be used to control the center‐of‐mass motion of levitated particles, enhancing trap stiffness and enabling stable ...
Shah Jee Rahman +7 more
wiley +1 more source
Correlations without causation do not support claims of human-LLM reasoning alignment. [PDF]
Vankov II +4 more
europepmc +1 more source
Effect of COMT and UGT1A Variants on Clinical Response to Opicapone in Parkinson's Disease
Abstract Background Parkinson's disease (PD) is the second most common neurodegenerative disease. Symptomatic treatment is based on dopaminergic replacement. With disease progression, the initial benefit of levodopa becomes inconsistent, and motor complications emerge.
Elena Ojeda‐Lepe +15 more
wiley +1 more source

